LncRNA RP11-620J15.3 promotes HCC cell proliferation and metastasis by targeting miR-326/GPI to enhance glycolysis

[1]  Yufeng Yuan,et al.  ncRNA-mediated fatty acid metabolism reprogramming in HCC , 2023, Trends in Endocrinology & Metabolism.

[2]  Yufeng Yuan,et al.  METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression , 2023, Cancer communications.

[3]  Xiao Zhang,et al.  A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma , 2022, Scientific Reports.

[4]  Dawei Li,et al.  Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications , 2022, Journal of Hematology & Oncology.

[5]  J. Pouysségur,et al.  'Warburg effect' controls tumor growth, bacterial, viral infections and immunity - Genetic deconstruction and therapeutic perspectives. , 2022, Seminars in cancer biology.

[6]  Xiao Zhang,et al.  A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression , 2022, Molecular metabolism.

[7]  J. Hoheisel,et al.  Transcription factor TFE3 enhances cell cycle and cancer progression by binding to the hTERT promoter , 2021, Cancer communications.

[8]  Yufeng Yuan,et al.  MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma , 2021, Cell Death & Disease.

[9]  D. Andrews,et al.  MYC protein interactors in gene transcription and cancer , 2021, Nature Reviews Cancer.

[10]  P. Fisher,et al.  Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. , 2021, Advances in cancer research.

[11]  Hyun-soo Cho,et al.  Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma , 2020, Cancers.

[12]  W. Dai,et al.  Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma , 2020, Journal of Experimental & Clinical Cancer Research.

[13]  Guixia Wang,et al.  Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect , 2020, Cancer management and research.

[14]  Weifeng He,et al.  The role of long noncoding RNAs in hepatocellular carcinoma , 2020, Molecular Cancer.

[15]  Yihai Liu,et al.  A comparison between drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis of six randomized controlled trials , 2020, Journal of cancer research and therapeutics.

[16]  M. Kreutz,et al.  The immunological Warburg effect: Can a metabolic‐tumor‐stroma score (MeTS) guide cancer immunotherapy? , 2020, Immunological reviews.

[17]  Yihai Liu,et al.  A comparison between radiofrequency ablation combined with transarterial chemoembolization and surgical resection in hepatic carcinoma: A meta-analysis , 2019, Journal of cancer research and therapeutics.

[18]  M. Heikenwalder,et al.  From NASH to HCC: current concepts and future challenges , 2019, Nature Reviews Gastroenterology & Hepatology.

[19]  Wei Yang,et al.  A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis , 2019, Molecular Cancer.

[20]  H. El‐Serag,et al.  Epidemiology and Management of Hepatocellular Carcinoma. , 2019, Gastroenterology.

[21]  M. Botelho,et al.  Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment? , 2018, Current cancer drug targets.

[22]  M. Yun,et al.  Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma , 2018, Yonsei medical journal.

[23]  J. Llovet,et al.  Molecular therapies and precision medicine for hepatocellular carcinoma , 2018, Nature Reviews Clinical Oncology.

[24]  J. Pouysségur,et al.  Metabolic Plasiticy in Cancers—Distinct Role of Glycolytic Enzymes GPI, LDHs or Membrane Transporters MCTs , 2017, Front. Oncol..

[25]  Cun-Yu Wang,et al.  STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4 , 2017, Molecular Cancer.

[26]  Panagiotis Kotsantis,et al.  Increased global transcription activity as a mechanism of replication stress in cancer , 2016, Nature Communications.

[27]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..